Baseline characteristics of patients predicting suitability for rapid naltrexone induction.

@article{Mogali2015BaselineCO,
  title={Baseline characteristics of patients predicting suitability for rapid naltrexone induction.},
  author={S. Mogali and N. Khan and Esther S Drill and M. Pavlicova and M. Sullivan and E. Nunes and A. Bisaga},
  journal={The American journal on addictions},
  year={2015},
  volume={24 3},
  pages={
          258-64
        }
}
  • S. Mogali, N. Khan, +4 authors A. Bisaga
  • Published 2015
  • Psychology, Medicine
  • The American journal on addictions
  • BACKGROUND AND OBJECTIVES Extended-release (XR) injection naltrexone has proved promising in the treatment of opioid dependence. Induction onto naltrexone is often accomplished with a procedure known as rapid naltrexone induction. The purpose of this study was to evaluate pre-treatment patient characteristics as predictors of successful completion of a rapid naltrexone induction procedure prior to XR naltrexone treatment. METHODS A chart review of 150 consecutive research participants (N = 84… CONTINUE READING
    10 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone
    • 3
    Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
    • 43
    • PDF
    Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
    • 9
    Extended‐release injectable naltrexone for opioid use disorder: a systematic review
    • 65
    Opioid antagonists with minimal sedation for opioid withdrawal.
    • 16

    References

    SHOWING 1-10 OF 34 REFERENCES
    Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    • 40
    A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.
    • 26